Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats.

Lesions of cholinergic neurons have been found by many investigators to impair choice accuracy in the radial arm maze. Because muscarinic receptor blockers, such as scopolamine, have also repeatedly been found to impair choice accuracy in the radial-arm maze, it has generally been thought that the critical effect of cholinergic lesions is the deafferentation of muscarinic receptors. The possible involvement of nicotinic receptors in the cholinergic bases of cognitive performance in the radial-arm maze has not been as well investigated. The present study examined the effects of the blockade of nicotinic receptors on performance of female Sprague-Dawley rats in the radial-arm maze. Acute administration of the the nicotinic receptor blocker, mecamylamine (10 mg/kg) was found to significantly impair radial-arm maze choice accuracy. This dose also caused a significant increase in response latency in the maze. The effect on choice behavior but not locomotor speed seemed to be due to the central effects of mecamylamine, because administration of the peripheral nicotine receptor blocker, hexamethonium (20 mg/kg), did not impair choice accuracy, even though it did increase response latency to a similar degree as the 10-mg/kg dose of mecamylamine. Lower doses of mecamylamine (2.5 and 5 mg/kg) did not impair choice accuracy. These results indicate that central nicotinic as well as muscarinic cholinergic receptors are involved with cognitive functioning.

[1]  Winford A. Gordon,et al.  Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat , 1980, Pharmacology Biochemistry and Behavior.

[2]  D. Olton,et al.  Animal Behavior Processes , 2022 .

[3]  S. Rauch,et al.  Cholinergic mediation of spatial memory in the preweanling rat: application of the radial arm maze paradigm. , 1984, Behavioral neuroscience.

[4]  Antonio Caprioli,et al.  Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice , 1985, Behavioural Brain Research.

[5]  F. Gage,et al.  Hippocampal connections and spatial discrimination , 1978, Brain Research.

[6]  D. Olton,et al.  Memory impairments following basal forebrain lesions , 1985, Brain Research.

[7]  J. Coyle,et al.  Nicotinic acetylcholine binding sites in Alzheimer's disease , 1986, Brain Research.

[8]  L. Jarrard,et al.  Scopolamine impairs performance of a place and cue task in rats. , 1982, Behavioral and neural biology.

[9]  Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. , 1969, Archives internationales de pharmacodynamie et de therapie.

[10]  H. Fibiger,et al.  Learning and memory deficits after lesions of the nucleus basalis magnocellularis: Reversal by physostigmine , 1985, Neuroscience.

[11]  J. R. Rush,et al.  Scopolamine does not disrupt spatial working memory in rats , 1982, Pharmacology Biochemistry and Behavior.

[12]  R. Stevens.  Scopolamine impairs spatial maze performance in rats , 1981, Physiology & Behavior.

[13]  Richard A. Martin,et al.  Scopolamine effects on delayed spatial alternation in the rat , 1975, Pharmacology Biochemistry and Behavior.

[14]  S. H. Snyder,et al.  In vivo identification of muscarinic cholinergic receptor binding in rat brain. , 1974, Brain research.

[15]  A. Levy,et al.  Radial arm maze performance of mice: acquisition and atropine effects. , 1983, Behavioral and neural biology.

[16]  O. Steward,et al.  Medial septal area lesions disrupt theta rhythm and cholinergic staining in medial entorhinal cortex and produce impaired radial arm maze behavior in rats , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[18]  E. Levin,et al.  Scopolamine effects on Hamilton search task performance in monkeys , 1986, Pharmacology Biochemistry and Behavior.

[19]  R. Bartus,et al.  Short-term memory in the rhesus monkey: Disruption from the anti-cholinergic scopolamine , 1976, Pharmacology Biochemistry and Behavior.

[20]  M. Aceto,et al.  Nicotine binding sites and their localization in the central nervous system , 1981, Neuroscience & Biobehavioral Reviews.

[21]  James L. McGaugh,et al.  Attenuation of experimentally-induced amnesia , 1981, Progress in Neurobiology.

[22]  S. L. Dilts.  Berry CA: Effect of cholinergic drugs on passive avoidance in the mouse. , 1967, The Journal of pharmacology and experimental therapeutics.

[23]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[24]  J. M. Novak,et al.  Medial septal lesions, radial arm maze performance, and sympathetic sprouting: a study of recovery of function , 1983, Brain Research.